{
    "clinical_study": {
        "@rank": "1502", 
        "arm_group": [
            {
                "arm_group_label": "PO", 
                "description": "administrated by per oral"
            }, 
            {
                "arm_group_label": "IV", 
                "description": "Administrated by intravenous"
            }, 
            {
                "arm_group_label": "SL", 
                "description": "administrated by sublingual"
            }
        ], 
        "brief_summary": {
            "textblock": "Compare 24-hour intragastric pH and therapeutic effectiveness of proton pump inhibitor (PPI)\n      among different administration methods: per oral (PO), intravenous (IV), and sublingual\n      (SL)."
        }, 
        "brief_title": "Sublingual Administration of PPI", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Gastric or Duodenal Ulcer", 
        "condition_browse": {
            "mesh_term": [
                "Duodenal Ulcer", 
                "Ulcer"
            ]
        }, 
        "detailed_description": {
            "textblock": "Intragastric pH and therapeutic effectiveness of PPI was compared among patients given PPI\n      with different administration methods. 24 hour intragastric pH catheter was inserted in\n      stomach of patients with peptic ulcer an hour prior to PPI administration in order to\n      observe the initial change in pH. Three groups of patients were given PPI through per oral,\n      intravenous, and sublingual administration methods. The hypothesis of this study is that\n      sublingual administration will be faster than oral or IV administration in PPI dosing with\n      respect to intragastric pH change and re-bleeding rate."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with peptic ulcer disease\n\n          -  Age: 20-75 years old\n\n          -  Patients who submitted informed consent\n\n        Exclusion Criteria:\n\n          -  Peptic ulcer disease with spurting and oozing\n\n          -  Shock, hypotension, pregnancy\n\n          -  Gastrointestinal malignancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "3 groups, each group with 20 subject with peptic ulcer ages between 20 to 75"
            }
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01926600", 
            "org_study_id": "24 hour pH"
        }, 
        "intervention_browse": {
            "mesh_term": "Proton Pump Inhibitors"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "gastric ulcer", 
            "duodenal ulcer", 
            "re-bleeding rate", 
            "intragastric pH", 
            "proton pump inhibitor"
        ], 
        "lastchanged_date": "August 20, 2013", 
        "location": {
            "contact": {
                "email": "jikim@catholic.ac.kr", 
                "last_name": "Jin Il Kim, MD", 
                "phone": "82-2-3779-1519"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "150-713"
                }, 
                "name": "St.Mary's Hopspital of the Catholic University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "3", 
        "official_title": "Sublingual Administration is More Fast Than Oral or IV Administration in PPI Dosing With Respect to Intragastric pH and Therapeutic Effectiveness: a Prospective, Randomized, Controlled Trial", 
        "overall_contact": {
            "email": "jikim@catholic.ac.kr", 
            "last_name": "Jin Il Kim, MD", 
            "phone": "82-2-3779-1519"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Ministry for Health, Welfare and Family Affairs", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Measure 24-hour intragastric pH", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01926600"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Catholic University of Korea", 
            "investigator_full_name": "Jin Il Kim", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "The Catholic University of Korea", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "The Catholic University of Korea", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}